LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a statement on Friday, the EU drug regulator said its evaluations of lenacapavir, sold as Yeytuo in Europe by Gilead Sciences, showed the drug is “highly effective” and “considered to be of …
Read More »Cyptea Daily News
Breaking News
- Haze settles over region as air quality dips – Times Union
- Military bases revert to original names with different namesakes
- ‘Get over it’: some middle America Trump supporters remain unfazed over Epstein files tumult | Donald Trump
- How Trump and trade wars pushed Russia and Ukraine into the cold
- Walmart stabbing: Multiple people stabbed at Traverse City, Michigan store, authorities say; suspect in custody